Stanford Health Policy is a joint effort of the Freeman Spogli Institute for International Studies and the Stanford School of Medicine
Education
Recent Publications
Records 24 / 2085
The practitioner's dilemma: can we use a patient's race to predict genetics, ancestry, and the expected outcomes of treatment?
December 2005
Recent research has identified genetic traits that can be used in a laboratory setting to distinguish among global population groups.
Frequency of HIV Screening in the Veterans Health Administrations: Implications for Early Diagnosis of HIV Infection
December 2008
We evaluated the frequency of HIV testing across the Department of Veterans Affairs (VA), the largest provider of HIV care in the United States.
Evaluating Human Papillomavirus Vaccination Programs
November 2004
Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials.
Can Technology Assessment Control Health Spending?
December 1994
Because medical technology is the most important controllable component of health spending growth, the success of strategies for limiting spending growth depends upon their impact on technology...
Cost-Effectiveness of Three Methods to Enhance the Sensitivity of Papanicolaou Testing
December 1999
Also a 1998 research report: Medical Advisory Panel, TEC Program, Blue Cross Blue Shield Association
People
Stephen P. Luby Senior Fellow Professor, Medicine, Senior Fellow, Woods Institute for the Environment, Professor, Epidemiology & Population Health (by courtesy) 
